All posts in CBD News

This is Oden, the newest addition to our family. Some people thought we were crazy as we have three kids, the youngest just nine months older than our pup. He definitely helps keep us on our toes! He loves digging, exploring our clothes with his mouth (everything has “Oden holes” now), and getting into trouble with the mini human whenever he can. Katie Freeze Stonington My Pet Pal is a reader-submitted feature that highlights local residents and their favorite furry, feathery or scaly friends. Send a photo of you and your pet, along with a short description of what makes…

New York Hemp Plan Approved By USDA | High Times Total 22 Share

A top federal health agency is seeking to promote studies into the efficacy of a variety of harm reduction policies—including decriminalization and safe consumption sites—as part of a push to combat the overdose epidemic. While the Biden administration has yet to take a position on policy proposals to authorize safe consumption facilities, the National Institutes of Health (NIH) put out a pair of requests for applications (RFAs) on Wednesday for an effort that will provide funding for efforts to investigate how that and other harm reduction policies could help address the drug crisis. Specifically, NIH wants to establish a Harm…

Pakistani official harvests 1st hemp plants; MT marijuana sales start soon; Researcher uses Reddit to study legalization arguments Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… Paid for by readers like you. Marijuana Moment’s newsletter and in-depth cannabis reporting is made possible by the 700+ people who subscribe to us on Patreon. Support our work for $25/month and gain access to valuable insider data, exclusive interview audio, and more: https://www.patreon.com/marijuanamoment/ TOP THINGS TO KNOWRep. Matt…

Connecticut is proposing an official change to the total amount of mold and yeast allowed in cannabis products following patient outcry over a change that allowed one of Connecticut’s labs to increase its total limit last year. The move would set the total limit at 100,000 colony forming units per gram, and wouldn’t allow any detectable levels of certain harmful breeds of mold in the Aspergillus family. It would mean an increase for limits at one Connecticut lab and a decrease for the other. The state’s Department of Consumer Protection opened public comment on the change Wednesday. The public comment…

With the passage of Friday’s deadline for New York municipalities to opt out of allowing marijuana retailers and consumption sites in their jurisdictions, hundreds of cities, towns and villages across the state will allow cannabis businesses to operate. However, there are still a significant number of areas where cannabis commerce won’t be immediately permitted, with one list from the Rockefeller Institute counting 642 dispensary opt-outs and 733 consumption site opt-outs as of Sunday. But while the institute’s dashboard is regularly updated, it notes that it “does not represent real-time, official information on municipalities’ opt-out decisions.” ….information from municipalities will still…

Another study has found that decriminalizing marijuana not only significantly decreases arrests for possession overall but that it also reduces racial disparities in any remaining arrests. Researchers at the University of California, San Diego examined FBI Uniform Crime Report data for 37 states between 2000 and 2019 to determine the impact of decriminalization policies. “Minorities often bear the brunt of unequal enforcement of drug laws,” the paper, which was published this month in the journal Social Science & Medicine,” notes. “In the U.S., Blacks have been disproportionately more likely to be arrested for cannabis possession than Whites despite a similar…

TEL AVIV, Israel, Dec. 29, 2021 /PRNewswire/ — SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), today provides updates regarding its activities in 2021. Itzhak Shrem, Chairman of the board of SciSparc, said, “We are excited to conclude a very eventful and successful year. We reached several important milestones, among them the uplisting of our ordinary shares to the Nasdaq Capital Market.” “Looking forward to 2022, we are aiming to show progress in our clinical programs in Tourette Syndrome (TS), Alzheimer’s disease…